Blood cancer drug attacks dormant HIV cells

An existing blood cancer drug has shown promise in killing 'silent' HIV cells and delaying reinfection, which could lead to a future cure for the disease.

Related Keywords

Denmark ,Melbourne ,Victoria ,Australia ,Philip Arandjelovic ,Youry Kim ,Sharon Lewin ,Doherty Institute ,Eliza Hall Institute Of Medical Research ,Peter Doherty Institute For Infection ,Cell Reports Medicine ,Eliza Hall Institute ,Medical Research ,Peter Doherty Institute ,Doherty Institute Director Professor Sharon Lewin ,Shiv ,Venetoclax ,Gbehi ,Cancer Drug ,Informant ,Antiretroviral Therapy ,